The Conversation is an independent, nonprofit publisher of commentary and analysis, authored by academics and edited by journalists for the general public. We publish short articles (800-1000 words) by academics on timely topics related to their research.
Our mission is “to promote truthful information and strengthen journalism by unlocking the rich diversity of academic research for audiences across America.”
Latest by The Conversation
"[I]ntegrating sexual health services and substance use care for gay and queer men who use meth can work."
People newly diagnosed with HIV must be able to access treatment and support, which could be improved if guided by people who have been taken the test themselves, researchers found.
Reseearchers have discovered that very rare interferons, only found in hunter-gatherers from central Africa, are far better able to inhibit HCV infection.
"The fight against AIDS is at a tipping point," Maureen Miller writes. "Increasingly, there are signs that we may be heading in the wrong direction."
"The operation, and subsequent events, have put us on the cusp of new insights and understanding about HIV and its transmission," Caroline T. Tiemessen writes.
A Chinese scientist claims to have edited human DNA to make us more resistant to HIV. Here's why that's not good news.
"We are not yet at the stage where aspirin can be recommended for preventing HIV, but the potential for another tool in our belt against a virus that has killed 35 million people (almost the population of Canada), can only be good news."
"A new approach is being piloted. The idea is to test if point-of-care viral load monitoring is in reach."
As a last resort, doctors in South Africa have tranplanted part of an HIV-positive woman's liver into her HIV-negative child.
The number of new hepatitis B virus and hepatitis C virus infections in the U.S. has been decreasing for many years, but this trend has been reversed during recent years due to the opioid epidemic as more people use injection drugs, share needles or ...